Should people with pulmonary fibrosis take nintedanib for life? Do I need to take this drug for life?

Nintedanib is an anti-fibrotic drug widely used to treat progressive interstitial lung diseases such as idiopathic pulmonary fibrosis (IPF). It can slow down the decline of lung function, thereby delaying the progression of the disease. However, it cannot cure pulmonary fibrosis, nor can it reverse the fibrotic tissue that has formed. Therefore, many patients need to take long-term medication to control the disease after diagnosis.

Whether nintedanib needs to be taken for life depends on the patient's specific condition and response to the drug. Some patients' condition is stable while taking it, and doctors may recommend continued maintenance treatment; while some patients may adjust or stop their medication if they experience significant side effects, change their condition, or have other treatment options. Medication regimens should usually be determined by a respiratory specialist based on individual assessment.

From the perspective of long-term management, treatment with nintedanib is more like a "controlled medication" process rather than a "time-limited" course of treatment. Patients need to undergo regular pulmonary function tests and imaging examinations during use. Doctors will evaluate the efficacy and necessity based on the examination results and clinical manifestations. Once the medication is stopped, some patients may be at risk of accelerated worsening of the condition, so they should not stop taking the medication on their own.

In general, most patients with pulmonary fibrosis may indeed need to take nintedanib long-term or even lifelong to maintain the stability of their disease. In order to minimize adverse reactions while controlling the disease, patients should maintain close communication with their doctors and conduct regular reviews to ensure the safety and effectiveness of their medications.

Reference materials:https://en.wikipedia.org/wiki/Nintedanib